A history of gout was associated with worse outcomes in patients with obstructive coronary artery disease.
Data show an increased prevalence of psoriasis in patients with gout compared with patients without gout.
Gout may be a risk factor for the development of CKD stage ≥3.
For patients with gout, allopurinol is associated with a reduced risk for developing chronic kidney disease stage ≥3.
An expert panel evaluated 23 separate statements related to the etiology, diagnosis, and treatment of gout.
Study reveals an 11% prevalence of active gout among solid organ transplant recipients overall and a 13% prevalence among kidney transplant recipients.
Ultrasound can show decreased urate deposition after urate lowering therapy.
Patients with gout who did not reach a serum uric acid level below 6 mg/dL had a 2.4-fold increased risk for death.
Gout may be associated with a higher risk for incident PD in older adults.
In a British study, nurse-led care emphasizing patient education and engagement significantly improved the proportion of gout sufferers who achieved target serum urate levels.
Rheumatology Advisor Articles
- 5-Step Guide to Activity Tracker Use for Patients With Rheumatic Diseases
- Gout Associated With Worse Outcomes in Obstructive Coronary Artery Disease
- Filgotinib Effective for Treatment of Active Psoriatic Arthritis
- Standard Set of Outcomes Developed for Value-Based Health Care in Inflammatory Arthritis
- Clinically Meaningful Improvement in Rheumatoid Arthritis Assessed With RAPID-3
- Circadian Rhythm in Rheumatoid Arthritis: Using Chronotherapy to Improve Outcomes
- Transcutaneous Electrical Nerve Stimulation Reduces Pain, Fatigue in Fibromyalgia
- Aspirin, Anticoagulants Similarly Prevent VTE After TKA
- Study: Cold Weather Joint Pain and Other Weather-Related Pain
- Increased Opioid Prescribing Linked to Chronic Usage in Patients With RA
- Treatment Retention Rates Lower in Patients Switching From Originator to Biosimilar Etanercept
- Climate Change Expected to Lead to Rise in Lyme Disease
- Red Cell Distribution Width Linked to Cardiovascular Disease Risk Factors in Spondyloarthritis
- Higher Biologic Drug Survival in JIA With Younger Age at Treatment Initiation
- Enough Is Enough? When Health Metrics Shift From Useful to Too Much